Get the Stockscreener App
8.235
0.67%
0.055
After Hours:
8.31
0.075
+0.91%
Mind Medicine Inc Stock (MNMD) Latest News
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 9%Here's What Happened - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 5.5%Still a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
What is HC Wainwright's Forecast for MNMD FY2029 Earnings? - MarketBeat
Mind Medicine’s LSD Therapy Could Revolutionize Anxiety Treatment – Is It a Buy? - PUNE.NEWS
Mind Medicine (MNMD) Advances Groundbreaking LSD Treatment - Markets Insider
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Stock Price Up 10.9% – Still a Buy? - Defense World
BlackRock, Inc.'s Strategic Acquisition of Mind Medicine Inc Sha - GuruFocus.com
Leerink Partnrs Issues Negative Forecast for MNMD Earnings - MarketBeat
MindMed to Present at Oppenheimer Healthcare Conference - TipRanks
Inside MindMed's Next Big Move: Key Revelations Expected at Oppenheimer Healthcare Conference - StockTitan
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of “Buy” by Brokerages - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5%Time to Buy? - MarketBeat
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's Why - MarketBeat
Analysts Issue Forecasts for MNMD FY2029 Earnings - Defense World
Mind Medicine (MindMed)’s (MNMD) Buy Rating Reiterated at HC Wainwright - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Earns Outperform Rating from Analysts at Evercore ISI - MarketBeat
Equities Analysts Issue Forecasts for MNMD Q1 Earnings - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat
JPMorgan Chase & Co. Buys 2,797 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Analysts at Evercore ISI - MarketBeat
MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan
MindMed doses first subject in Phase III Panorama study of GAD tablet - Clinical Trials Arena
symbol__ Stock Quote Price and Forecast - CNN
Equities Analysts Set Expectations for MNMD Q1 Earnings - Defense World
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder - The Globe and Mail
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety - TipRanks
Mindmed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of Mm120 in Generalized Anxiety Disorder - Marketscreener.com
MindMed launches phase 3 trial for anxiety treatment - Investing.com
(MNMD) Trading Signals - Stock Traders Daily
Revolutionary Anxiety Treatment: MindMed's LSD Therapy Enters Final Testing Stage - StockTitan
MindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' Call (MNMD) - Seeking Alpha
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish - MSN
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):